2020
DOI: 10.1016/j.ajic.2019.12.011
|View full text |Cite
|
Sign up to set email alerts
|

Low prevalence of Clostridium difficile colonization in patients in long-term care facilities in Graz, Austria: A point-prevalence study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…All carbapenem-resistant strains detected by screening culture and confirmed by Carba5 test were further investigated by a home-made PCR using published primers and conditions ( Poirel et al., 2011 ), targeting bla KPC, bla VIM , bla IMP, bla OXA-48 , bla NDM, bla OXA-23 and bla OXA-24 type genes, to identify on single isolated strains the presence of specific genes encoding for carbapenemase. All fecal samples were analyzed with Premier C. difficile GDH qualitative enzyme immunoassay ( Meridian Bioscience Europe S.r.l.- Italy) screening test to detect Clostridioides difficile glutamate dehydrogenase (GDH) ( Terveer et al., 2017 ; Leitner et al., 2020 ). All GDH-positive specimens were further tested with Illumigene® ( Meridian Bioscience Europe S.r.l.- Italy), a loop-mediated isothermal amplification assay (LAMP) to detect a gene segment of the tcdA gene in the pathogenicity locus (PaLoc) present in all known toxigenic C. difficile strains.…”
Section: Methodsmentioning
confidence: 99%
“…All carbapenem-resistant strains detected by screening culture and confirmed by Carba5 test were further investigated by a home-made PCR using published primers and conditions ( Poirel et al., 2011 ), targeting bla KPC, bla VIM , bla IMP, bla OXA-48 , bla NDM, bla OXA-23 and bla OXA-24 type genes, to identify on single isolated strains the presence of specific genes encoding for carbapenemase. All fecal samples were analyzed with Premier C. difficile GDH qualitative enzyme immunoassay ( Meridian Bioscience Europe S.r.l.- Italy) screening test to detect Clostridioides difficile glutamate dehydrogenase (GDH) ( Terveer et al., 2017 ; Leitner et al., 2020 ). All GDH-positive specimens were further tested with Illumigene® ( Meridian Bioscience Europe S.r.l.- Italy), a loop-mediated isothermal amplification assay (LAMP) to detect a gene segment of the tcdA gene in the pathogenicity locus (PaLoc) present in all known toxigenic C. difficile strains.…”
Section: Methodsmentioning
confidence: 99%